We identified reports by MEDLINE search through the PubMed database (1986ā2002) by combining the keywords āpancreatic cancerā with the following topics: carcinogenesis, angiogenesis, progression, metastasis, pathology, pathobiology, pathophysiology, molecular genetics, and genetics. We searched citation lists in retrieved papers to identify additional references. Papers were selected on the basis of the best available evidence for each specific question discussed. To limit the number of
SeminarPancreatic cancer
Section snippets
Epidemiology and molecular epidemiology
In many studies risk factors associated with pancreatic cancer have been explored (panel). The only risk factors consistently reported are age and cigarette smoking.2 Cigarette smoking is estimated to account for 25ā29% of pancreatic cancer incidence, with reported odds ratios ranging from 1Ā·6 to 5Ā·4.3 Another risk factor for pancreatic cancer might be family history.4, 5 Several genetic syndromes are associated with an increased risk of pancreatic cancer, including hereditary pancreatitis,
Molecular pathology
In the past few years, our knowledge of the pathogenesis of pancreatic cancer has been significantly advanced due to the rapid accumulation of our understanding of the molecular biology of the disease. Like many other malignant diseases, pancreatic ductal carcinoma results from the accumulation of acquired mutations (table 1). The multigenic nature of most pancreatic ductal cancers is reflected in the abnormalities of three broad classifications of genesāie, oncogenes, tumour-suppressor genes,
Diagnosis and management
For most patients diagnosed as having cancer of the exocrine pancreas life expectancy is measured in months. Three factors underlie this poor outlook. First, pancreatic cancer disseminates to distant sites early in its natural history. Second, as the disease progresses it is associated with substantial morbidity, characterised by cachexia and asthaenia. Third, pancreatic cancer is resistant to most forms of treatment studied to date.
Diagnosis and staging
For patients who present with painless jaundice, the diagnostic work-up is generally straightforward. CT of the abdomen is recommended as the first diagnostic procedure rather than endo-scopic retrograde cholangiopancreatog-raphy because the appearance of the biliary tree and the pancreas are better defined before endoscopic retrograde cholangiopancreatography and stent placement. Once the biliary tree has been manipulated, visualisation of small tumours might be obscured on CT because of the
Preoperative chemoradiation for resectable pancreatic cancer
In single-institution and multicentre trials 20ā30% of patients who undergo pancreaticoduodenectomy are not eligible for postoperative chemoradiation. Therefore, preoperative chemoradiation for patients with resectable disease has been advocated by some groups. The rationale for this approach is sound. First, all patients who have potentially resectable disease receive the treatment. Second, a subset of patients will develop overt metastatic disease in the 8ā12 weeks of preoperative treatment
The way forward
Pancreatic cancer will remain a challenging problem into the 21st century. However, improvements in early detection, screening, and staging of patients will be expected to facilitate progress in the management of patients with this disease. Most promising, is the potential to base treatment on our rapidly evolving understanding of the molecular biology of pancreatic cancer. Already various agents are being developed that target signal-transduction pathways or nuclear transcription factors. In
Search strategy and selection criteria
References (103)
- et al.
Genetics of pancreatic cancer: from genes to families
Surg Oncol Clin N Am
(1998) - et al.
DNA adducts, genetic polymorphisms, and K-ras mutation in human pancreatic cancer
Mutat Res
(2002) - et al.
Comparison of DNA adduct levels associated with exogenous and endogenous exposures in human pancreas in relation to metabolic genotype
Mutat Res
(1999) - et al.
Comparison of DNA adduct levels associated with oxidative stress in human pancreas
Mutat Res
(1998) - et al.
Serum concentrations of organochlorine compounds and K-ras mutations in exocrine pancreatic cancer
Lancet
(1999) - et al.
The molecular genetics of pancreatic ductal carcinoma: a review
Surg Oncol
(2000) - et al.
Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: comparison with K-ras mutations
Am J Gastroenterol
(1999) - et al.
BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications
Am J Pathol
(2000) Role of growth factors in pancreatic cancer
SurgOncolClinN Am
(1998)Interleukin-8 and human cancer biology
CytokineGrowth Factor Rev
(2001)
The human gene for vascular endothelial growth factor: multiple protein forms are encoded through alternative exon splicing
J Biol Chem
Randomized trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction
Lancet
Ultrasound-guided fine needle biopsy of pancreatic masses: results of a multicenter study
Am J Gastroenterol
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial
Lancet
Continuing controversy over adjuvant therapy of pancreatic cancer
Lancet
Adjuvant therapy in pancreatic cancer: historical and current perspectives
Ann Oncol
The role of radiation therapy in the control of pain from pancreatic carcinoma
J Pain Symptom Manage
A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer
AnnOncol
Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine for advanced pancreatic adenocarcinoma (FOLFUGEM)
Ann Oncol
Cancer statistics, 2003
CA Cancer J Clin
Pancreatic cancer
A review of the epidemiology and pathology of pancreas cancer
Gastrointest Cancer
Garabrant familial risk of pancreatic cancer
J Natl Cancer Inst
Dietary factors and the risk of pancreatic cancer: a case-control study in Shanghai, China
CancerEpidemiol Biomarkers Prev
Food habits and pancreatic cancer: a case-control study of the francophone community in Montreal, Canada
Cancer Epidemiol Biomarkers Prev
Dietary and other methyl-group availability factors and pancreatic cancer risk in a cohort of male smokers
Am J Epidemiol
Pancreatic cancer and occupational exposures
Epidemiology
DDT and related compounds and risk of pancreatic cancer
J Natl Cancer Inst
A case-control study of self-reported exposures to pesticides and pancreas cancer in Southern Michigan
Int J Cancer
DNA adducts in human pancreatic tissues and their potential role in carcinogenesis
CancerRes
Genetic polymorphism of N-acetyltransferases, glutathione S-transferase M1 and NAD(P)H:quinone oxidoreductase in relation to malignant and benign pancreatic disease risk: the International Pancreatic Disease Study Group
Eur J Cancer Prev
Polymorphisms in GSTM1, GSTT1 and CYP1A1 and risk of pancreatic adenocarcinoma
Br J Cancer
Apopulation-based, case-control study of polymorphisms in carcinogen-metabolizing genes, smoking, and pancreatic adenocarcinoma risk
J Natl Cancer Inst
A population-based study of the Arg399Gln polymorphism in X-ray repair cross-complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma
Cancer Res
Codon 143 polymorphism of AGT gene in pancreatic cancer
Proc Am Assoc Cancer Res
K-ras mutations in exocrine pancreatic cancer: association with clinico-pathological characteristics and with tobacco and alcohol consumption
Int J Cancer
Mutational activation of K-ras in non-neoplastic exocrine pancreatic lesions in relation to cigarette smoking status
Cancer
Occupational exposure to organic solvents and K-ras mutations in exocrine pancreatic cancer
Carcinogenesis
Molecular biology of pancreatic cancer: potential clinical implications
BioDrugs
Progression model for pancreatic cancer
Clin Cancer Res
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
Cell
K-ras mutations in tissue and stool samples from patients with pancreatic cancer and chronic pancreatitis
Langenbecks Arch Surg
Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma
Nat Genetics
Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas
Cancer Res
Loss of expression of DPC4 in pancreatic intrapithelial neoplasia (PanIN): evidence that DPC4 inactivation occurs late in neoplastic progression
Cancer Res
DPC4, a candidate tumor-suppressor gene at 18q21.1
Science
Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene
Cancer Res
Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers
Am J Pathol
Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients
Nat Genet
Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas
CancerRes
Cited by (1838)
Multifunctional chitosan-bimetallic nanocarrier deliver 5-fluorouracil for enhanced treatment of pancreatic and triple-negative breast cancer
2024, International Journal of Biological MacromoleculesAutomated screening of primary cell-based aptamers for targeting and therapy of pancreatic cancer
2024, Chinese Chemical LettersCircNEK6 promotes the progression of pancreatic ductal adenocarcinoma through targeting miR-503/CCND1 axis
2024, Translational Oncology